Gilead Sciences’ experimental drug remdesivir has been gaining traction as a potential Covid-19 treatment, and late last week scored an emergency use authorization from federal regulators for it to be used in patients with the condition.

Preliminary data released last week from a closely watched trial run by the National Institute of Allergy and Infectious Diseases showed that Covid-19 patients who were given remdesivir recovered faster than those who received a placebo.

Remdesivir was originally created as a general antiviral and was later tested in Ebola patients, though it did not perform well in a landmark trial. Watch the explainer above to learn how remdesivir works against the SARS-CoV-2 virus, which causes Covid-19.

https://www.statnews.com/2020/05/04/...s/?jwsource=cl

India To Test 1,000 Doses of Remdesivir On Patients

Minister of Health and Family Welfare Harsh Vardhan has said India is part of World Health Organisation's (WHO) solidarity trials to combat coronavirus and has received 1,000 doses of Remdesivir, which will be tested on some patients across states.